BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $192,000 | – | 16,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $7,760,000 | 1.61% |
| X-Square Capital, LLC | 102,832 | $759,000 | 0.57% |
| CORRADO ADVISORS, LLC | 78,945 | $582,000 | 0.35% |
| Endurant Capital Management LP | 71,801 | $530,000 | 0.23% |
| Baker Brothers Advisors | 4,093,447 | $30,210,000 | 0.23% |
| KNOTT DAVID M | 76,653 | $566,000 | 0.21% |
| L & S Advisors Inc | 83,125 | $613,000 | 0.10% |
| DAFNA Capital Management LLC | 30,000 | $221,000 | 0.10% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $14,760,000 | 0.09% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $230,000 | 0.09% |